Byron Pickard, managing director of Sterne, Kessler, Goldstein & Fox, is an experienced first-chair trial lawyer and appellate advocate. With an active practice in the firm’s Trial and Appellate Group, Byron is known for representing clients in complex IP litigation matters across a broad spectrum of technologies, especially in the biotechnology and high-tech sectors.

Byron has tried cases in courts across the country. His recent wins include obtaining an $83.4 million jury verdict of willful infringement against a publicly traded oncology company, a summary judgement victory that allowed a biotechnology start-up client to close on a major exit transaction, a successful pursuit of a motion to dismiss for lack of standing that wiped out a claim for lost profits on behalf of a pharmaceutical start-up client, and a preliminary injunction for a patent owner against its sole competitor in a case involving electric field detection technology.

In addition to his trial work in district courts, Byron has argued dozens of appeals before the U.S. Courts of Appeals and has appeared in dozens of additional appellate matters in disparate technical fields involving virtual machines, electronic storage and back-up, digital rights management, wireless communications, business methods, public utility safety systems, and nucleic acid sequencing.

When not appearing in court, Byron regularly represents clients before the U.S. Patent and Trademark Office in post-grant proceedings, where he has handled more than 100 inter partes review proceedings. Byron has obtained critical victories at the Patent Trial and Appeal Board (PTAB) for both patent owners and patent challengers that have furthered his clients’ business and litigation objectives. Byron is also a trusted advisor, regularly providing strategic advice that allows his clients to achieve their business goals without resorting to litigation, including guiding his clients in managing threats from non-practicing entities and in negotiating patent licenses.

As managing director, Byron works closely with firm leadership, including the Executive Committee and Chair, to steer strategic initiatives for the firm. Before his election to managing director, Byron served on the firm’s Executive Committee for six years and as Practice Group Leader and Co-Practice Group Leader of the firm’s Trial and Appellate Group.

Byron is a frequent writer and speaker on complex patent issues offering insightful analysis and practical advice to readers and audiences. He authored a chapter of Patent Office Litigation, Second Edition, published by Thomson Reuters Westlaw. In addition to his written works and speeches, Byron is a regular source for reporters who cover developments in the IP space.

Byron earned his J.D. at the University of Virginia School of Law and has a B.A. in economics, also from the University of Virginia.

District Court

  • Twinstrand Biosciences v. Guardant Heath (D. Del.) (oncology diagnostics)
  • Allergan, Inc. v. Revance Therapeutics, Inc. (D. Del.) (pharma.)
  • Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del.) (pharma.)
  • Hybir, Inc. v. Veeam Software Corporation (D. Del.) (data storage and restoration)
  • TrustID v. Next Caller (D. Del) (telecommunications)
  • TrustID v. Next Caller (D. Col.) (telecommunications)
  • Steuben Foods v. Shibuya (D. Del.) (industrial food processing)

Appellate

  • Hybir, Inc. v. Veeam Software Corporation (Fed. Cir.) (electronic storage and restoration)
  • Trading Technologies v. Interactive Brokers (Fed. Cir.) (electronic trading platform)
  • Ericsson v. Intellectual Ventures (Fed. Cir.) (wireless communications)

  • Patexia, “100 Best Performing Attorneys Representing Petitioners – Inter Partes Review” (2022)
  • Super Lawyers, “Super Lawyer – Washington DC” (2016 – 2025)
  • Patexia, “100 Most Active CAFC Attorneys Representing Patent Appellants (Top 50)” (2022)
  • Patexia, “100 Most Active CAFC Attorneys Overall (Representing Appellants and Appellees)” (2022)
  • Super Lawyers, “Rising Star – Washington DC” (2013 – 2015)
  • Bisnow Ventures, “Trending 40 Lawyers Under 40” (2015)

  • J.D., University of Virginia School of Law
  • B.A., Economics, University of Virginia

  • District of Columbia
  • Supreme Court of Virginia
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the Fourth Circuit
  • U.S. District Court for the District of Columbia
  • U.S. District Court for the Eastern District of Virginia
  • U.S. District Court for the Western District of Virginia
  • United States Bankruptcy Court, Eastern District of Virginia
  • United States Patent & Trademark Office
  • Virginia

Speaking Engagement

2023 Focus on Pharma

Washington, DC, April 14, 2023 8:30 AM - 6:00 PM EST

Speaking Engagement

IP Strategy Summit: Silicon Valley

Palo Alto, CA, June 13, 2017

Related News & Insights

From Byron L. Pickard

In the News

January 16, 2026

Longtime Sterne Kessler Head Reflects on Leadership

Law360 Multiple Authors

In the News

January 8, 2026

Amid Rapid Changes for IP Boutiques, Byron Pickard Discusses What’s Next for Sterne Kessler

The National Law Journal Multiple Authors

In the News

January 5, 2026

Sterne Kessler Names First New Managing Director Since 2007

Law360 Multiple Authors

Firm News

January 5, 2026

Sterne Kessler Elects Byron Pickard as Managing Director

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

June 2, 2025

Twenty Sterne Kessler Attorneys Recognized as 2025 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox Multiple Authors

Articles

February 13, 2025

2024 Federal Circuit IP Appeals – Pfizer Inc. v. Sanofi Pasteur Inc., 94 F.4th 1341 (Fed. Cir. 2024) (Lourie, Bryson, Stark)

Sterne, Kessler, Goldstein & Fox Byron L. Pickard

Reports

February 13, 2025

2024 Federal Circuit IP Appeals: Summaries of Key 2024 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

December 3, 2024

Sterne Kessler Invalidates Patent Claims Brought Against Veeam Software

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

July 10, 2024

Sterne Kessler Wins Appeal of PTAB Decision for Beable Education

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

April 25, 2024

Eighteen Sterne Kessler Attorneys Recognized as 2024 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

April 24, 2024

Sterne Kessler Secures Victory on Behalf of Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

January 25, 2024

Petition Watch: Patent Obviousness, ADA Trials, Spoofing

Law360 Multiple Authors

In the News

November 16, 2023

Delaware Jury: Guardant Willfully Infringed Patents With DNA Sequencing Kits

Mealey's Litigation Report: Intellectual Property, pub. 41094 Multiple Authors

In the News

November 15, 2023

Seattle Startup Wins $83M In IP Spat With Silicon Valley Rival

Law360 Multiple Authors

In the News

November 15, 2023

Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says

Reuters Multiple Authors

Firm News

November 15, 2023

Sterne Kessler Scores $83.4M Federal Jury Verdict for TwinStrand Biosciences, Inc.

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

October 11, 2023

DNA Sequencing Patent Survives Guardant PTAB Challenge

Law360 Multiple Authors

In the News

May 10, 2023

Sterne Kessler Represents Teva in Sleep Disorder Drug Win at Federal Circuit

Bloomberg Law Multiple Authors

Firm News

April 24, 2023

Super Lawyers Recognizes 14 Sterne Kessler Attorneys as 2023 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

March 15, 2023

Shibuya Sheds $38 Million Patent Loss With Noninfringement Order

Bloomberg Law Multiple Authors

In the News

March 14, 2023

Fed. Circ. Unsure Vanda’s Sleep Med Hetlioz Is Patentable

Law360 Multiple Authors

In the News

March 14, 2023

In Win for Client Shibuya, Judge Overturns Steuben Foods’ $38M Patent Trial Win

Law360 Multiple Authors

In the News

January 3, 2023

Fed. Circ. Won’t Bar Generic Sleep Meds Amid Vanda Appeal

Law360 Multiple Authors

In the News

December 13, 2022

Teva, Apotex Win Ax of Patents in Sleep Drug Suit

Law360 Multiple Authors

In the News

December 1, 2022

Patexia Insight 161: Top CAFC Law Firms of 2022

Patexia Multiple Authors

Firm News

November 21, 2022

Sterne Kessler and Its Attorneys Ranked Highly for Appellate Practice in Patexia’s 2022 CAFC Intelligence Report

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

November 10, 2022

Patexia Insight 158: Top IPR Firms of 2022

Patexia Multiple Authors

Firm News

October 11, 2022

Sterne Kessler Notches Top Rankings in 2022 IPR Intelligence Report Based on PTAB Case Volume and Results

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

September 12, 2022

Korean Co. Can’t Be First To Invent CRISPR, PTAB Told

Law360 Multiple Authors

Firm News

May 1, 2022

Super Lawyers Recognizes 14 Attorneys as 2022 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

July 26, 2021

Sterne, Kessler, Goldstein & Fox Earns 13 Market-Leading Awards for Excellence in the First Six Months of 2021

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

May 4, 2021

PTAB Faulted For Logic Behind Anti-Spoofing Patent Ruling

Law360 Multiple Authors

Firm News

April 27, 2021

Super Lawyers Recognizes 17 Sterne, Kessler, Goldstein & Fox Attorneys as 2021 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

October 8, 2020

Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

June 4, 2020

Fed. Circ. Says It Can’t Award Atty Fees Tied To PTAB Cases

Law360 Multiple Authors

Firm News

April 30, 2020

Sterne, Kessler, Goldstein & Fox Attorneys Named 2020 Super Lawyers and Rising Stars

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

February 14, 2020

Juul Rival Warned That TM Suit Is Nothing To ‘LOL’ About

Law360 Multiple Authors

Client Alert

February 3, 2020

IP Hot Topic: Federal Circuit Appeals from the PTAB: Summaries of Key 2019 Decisions

Jon E. Wright, Michael Joffre, Ph.D.

Firm News

February 3, 2020

Sterne, Kessler, Goldstein & Fox Summarizes Key Decisions in 2019 Federal Circuit Appeals From The PTAB Report

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Reports

January 24, 2020

Federal Circuit Appeals From The PTAB: Summaries of Key 2019 Decisions

Sterne, Kessler, Goldstein & Fox Multiple Authors

Articles

January 24, 2020

Honeywell International Inc. v. Arkema Inc., 939 F.3d 1345 (Fed. Cir. 2019)

Sterne, Kessler, Goldstein & Fox Byron L. Pickard

In the News

January 9, 2020

‘Indefensible’ Patent Eligibility Rule Must Go, Justices Told

Law360 Multiple Authors

In the News

December 20, 2019

SG Tells Justices To Skip ‘Unsuitable’ Abstract Patent Appeal

Law360 Multiple Authors

In the News

September 16, 2019

Invalidating Abstract Patents Isn’t Working, Justices Told

Law360 Multiple Authors

In the News

July 30, 2019

IBG, Broker Ask High Court To Clarify ‘Confusing’ CBM Rules

Law360 Multiple Authors

In the News

July 1, 2019

Fed. Circ. Lets Alice Invalidate Another Trading Tech Patent

Law360 Multiple Authors

In the News

May 14, 2019

Fed. Circ. Axes 4 More Trading Tech Patents Under Alice

Law360 Multiple Authors

In the News

April 18, 2019

Fed. Circ. Won’t Revive Alice-Axed Trading Tech Patents

Law360 Multiple Authors

Reports

February 19, 2019

2019 Report: Federal Circuit Appeals from the PTAB – Summaries of Key 2018 Decisions

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

February 4, 2019

Golf Club Makers Settle Sprawling 23-Patent Suit

Law360 Multiple Authors

In the News

October 31, 2018

Allergan, Generic Cos. Battle Over Restasis Launch Plans

Law360 Multiple Authors

In the News

September 28, 2018

Rocket-er Docket: Mass. IP Case Sees 2 Trials In 6 Months

Law360 Multiple Authors

In the News

August 22, 2018

Fed. Circ. Time-Bar Case Puts Pressure On Patent Defendants

Law360 Multiple Authors

In the News

August 21, 2018

Fed. Circ. Pushes Flexible Approach On ‘Printed Publications’

Law360 Multiple Authors

In the News

July 6, 2018

Patent Cases To Watch In The 2nd Half Of 2018

Law360 Multiple Authors

Reports

March 1, 2018

2018 Report: Federal Circuit Appeals from the PTAB – Summaries of Key 2017 Decisions

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

July 17, 2017

Fed. Circ. Backs PTAB Ruling Upholding Prison Phone Patent

Law360 Multiple Authors

In the News

June 6, 2017

Appealing PTAB Loss, IV Finds Tough Crowd at Fed. Circ.

Law360 Multiple Authors

Client Alert

May 25, 2017

The Supreme Court Limits What Constitutes Proper Venue

Multiple Authors

In the News

May 22, 2017

3 Takeaways From the Supreme Court’s Patent Venue Ruling

Law360 Multiple Authors

Firm News

April 11, 2017

Sterne, Kessler, Goldstein & Fox Attorneys Named 2017 Super Lawyers

Multiple Authors

Reports

March 7, 2017

2017 Report: Federal Circuit Appeals from the PTAB – Summaries of Key 2016 Decisions

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Books and Chapters

February 17, 2017

Patent Office Litigation – Second Edition 2017

Thomson Reuters Westlaw Multiple Authors

In the News

February 13, 2017

Week Ahead in Intellectual Property, Feb. 13, 2017

Reuters Multiple Authors

Articles

January 11, 2017

The Future of Forum-Shopping in a Post-TC Heartland World

IP Watchdog Byron L. Pickard, Joseph H. Kim

In the News

August 2, 2016

Intellectual Ventures Attacks Ericsson’s Prior Art At Fed. Circ.

Law360 Multiple Authors

Client Alert

June 14, 2016

SCOTUS Paves the Way for Enhanced Damages with Halo Ruling

Byron L. Pickard

Firm News

April 25, 2016

Sterne, Kessler, Goldstein & Fox Attorneys Named 2016 Super Lawyers

Multiple Authors

In the News

February 25, 2016

Fed. Circ. Affirms PTAB Upholding Of IV Processor Patent

Law360 Multiple Authors

Firm News

June 17, 2015

Sterne Kessler’s Pickard Named Top Lawyer Under 40

Multiple Authors

Firm News

April 16, 2015

Sterne, Kessler, Goldstein & Fox Attorneys Named 2015 Super Lawyers

Multiple Authors

Firm News

February 4, 2015

Veeam Invalidates Symantec’s Patents at the U.S. Patent and Trademark Office

Multiple Authors

In the News

August 1, 2014

Patent – PTAB: Some claims of Symantec’s computer restoration patent were made obvious by prior art

IP Law Daily Wrap Up Multiple Authors

Firm News

June 1, 2014

Sterne, Kessler, Goldstein & Fox Lawyers Named 2014 Super Lawyers

Multiple Authors

In the News

April 16, 2014

Glenmark Sues Sanofi to Clear Way for Antidiuretic

Law360 Multiple Authors

Books and Chapters

January 1, 2012

Patent Office Litigation

Thomson Reuters Westlaw Multiple Authors